← All organizations
Highest phase reached
Phase 3
First clinical trial
May 31, 2009Last known activity
Nov 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06677359Lead sponsorN/ANov 30, 2024
- NCT04438980Lead sponsorPhase 3May 15, 2020
- NCT04443881Lead sponsorPhase 2/Phase 3May 8, 2020
- NCT00941135Lead sponsorPhase 2May 31, 2009
Details
- Last known activity
- Nov 30, 2024